New melatonin insomnia product launched for children with ADHD

The UK’s first melatonin product for insomnia in children and adolescents aged 6-17 years old with attention deficit hyperactivity disorder (ADHD) has been launched. Melatonin is one of the most commonly used drugs for paediatric sleep problems, in particular those with neurodevelopmental related sleep disorders. However, even though up to 73% will of children with ADHD will experience sleep problems, there has been no melatonin treatment licensed for children with ADHD in the UK. Lack of sleep can worsen ADHD symptoms, have a negative impact on children’s emotions and behaviour, disrupt school performance, peer relations and family functioning. In a recent